Home › Triple-Negative Breast Cancer › NCT05677802

Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Examining the Feasibility of Implementing a Biobehavioral Stress Reduction Program in Triple Negative Breast Cancer Patients

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* Age \>=18 years
* Untreated newly diagnosed triple negative breast cancer
* Stages I-III

Exclusion Criteria:

* Prisoners
* Male
* Identifying as American Indian, Alaska Native, Asian, Native Hawaiian or Other Pacific Islander
* Individuals not able to speak and understand English
* Known personal history of ductal carcinoma in situ (DCIS) or invasive breast cancer
* Stage IV breast cancer

About the study

This clinical trial aims to see if patients with triple negative breast cancer can complete a biobehavioral stress reduction program that also addresses health related social needs (e.g., utilities, transportation, etc.). The stress reduction program is over ten weeks and includes stress reduction (e.g., progressive muscle relaxation), coping, problem solving, communication, and social support. Health related social needs will be evaluated at the beginning of the study, and referrals will be made to social work to help address those needs. The study will examine stress as reported by the patients and also use biological markers.

What is being tested

• Biospecimen Collection (procedure)
• Medical Chart Review (other)
• Stress Management Therapy (procedure)
• Survey Administration (other)

Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 40 · Started: Dec 14, 2022

Contact the study team

• The Ohio State Comprehensive Cancer Center · Phone: 800-293-5066

Official record on ClinicalTrials.gov — NCT05677802

Locations in the U.S.

Conditions

• Triple-Negative Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.